Keywords: دابیگاتران ; Cardioembolic stroke; dabigatran; idarucizumab; nonvalvular atrial fibrillation; recombinant tissue plasminogen activator;
مقالات ISI دابیگاتران (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دابیگاتران ; Acute ischemic stroke; intravenous thrombolysis; anticoagulation; dabigatran; antidote; reversal;
Keywords: دابیگاتران ; dabigatran; severe hemorrhage; life-threatening hemorrhage; anticoagulation; prothrombin complex concentrates; recombinant factor VIIa; factor eight inhibitor bypass activity; fresh frozen plasma;
Keywords: دابیگاتران ; Dabigatran; Rivaroxaban; Apixaban; Atrial fibrillation; Cancer; Anticoagulants;
Keywords: دابیگاتران ; Type 2 diabetes; Direct oral anticoagulants levels; Dabigatran; Rivaroxaban; Apixaban; Hemoclot® Thrombin Inhibitor Assay; Atrial fibrillation;
Keywords: دابیگاتران ; Idarucizumab; dabigatran; anticoagulation reversal; bleeding; surgery; thrombolysis;
Keywords: دابیگاتران ; Stroke; dabigatran; rivaroxaban; apixaban; edoxaban; oral anticoagulants;
Keywords: دابیگاتران ; Apixaban; Aspirin; Bleeding; Dabigatran; Direct-acting oral anticoagulant; Gastrointestinal; Hospitalization; Intervention; Mortality; Rivaroxaban; Severity; Transfusion; Warfarin;
Keywords: دابیگاتران ; Photolysis; Solar light irradiation; Surface water; Apixaban; Dabigatran; Rivaroxaban;
Keywords: دابیگاتران ; Deep Vein Thrombosis; Anticoagulant drugs; Thrombolytic therapy; Mechanical thrombolysis; Rivaroxaban; Apixaban; Edoxaban; Dabigatran; Warfarin;
Keywords: دابیگاتران ; dabigatran; direct oral anticoagulants; rivaroxaban; spontaneous spinal hematoma;
Keywords: دابیگاتران ; Antiplatelet drugs; apixaban; bleeding; dabigatran; direct oral anticoagulants; disseminated intravascular coagulation; edoxaban; liver disease; rivaroxaban; vascular abnormalities; vitamin K deficiency; warfarin;
Keywords: دابیگاتران ; Antiphospholipid syndrome; Direct oral anticoagulants; Rivaroxaban; Apixaban; Dabigatran; Thrombosis;
Keywords: دابیگاتران ; Anticoagulants; Warfarin resistance; Vitamin K antagonists; Non-vitamin K antagonist oral anticoagulants; NOACs; Dabigatran; Intracardiac thrombus; Thrombosis; Systemic embolism;
Keywords: دابیگاتران ; Lupus anticoagulant; New oral anticoagulants; Antiphospholipid syndrome; Rivaroxaban; Dabigatran;
Keywords: دابیگاتران ; Novel oral anticoagulants; Dabigatran; Rivaroxaban; Apixaban; New oral anticoagulants use assessment;
Keywords: دابیگاتران ; Absorption; Anticoagulation; Apixaban; Bariatric surgery; Biliopancreatic diversion; Bleeding; Dabigatran; Edoxaban; Efficacy; Gastrectomy; Gastric banding; Obesity; Pharmacokinetics; Rivaroxaban; Roux-en-Y; Safety; Thrombosis; Warfarin;
Keywords: دابیگاتران ; Apixaban; Dabigatran; DOACs; Edoxaban; Measurement; Reversal; Rivaroxaban;
Keywords: دابیگاتران ; Direct oral anticoagulant; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Randomized clinical trials;
Keywords: دابیگاتران ; Atrial fibrillation; Vitamin K antagonists; Dabigatran; Rivaroxaban; Apixaban;
Keywords: دابیگاتران ; Dabigatran; Mid-ventricular hypertrophic cardiomyopathy; Aneurysm; Thrombus; Cerebral hemorrhagic infarction;
Keywords: دابیگاتران ; Dabigatran; Rivaroxaban; Bleeding; Atrial fibrillation; Non-vitamin K oral antagonists
Keywords: دابیگاتران ; apixaban; dabigatran; postoperative bleeding; rivaroxaban; tooth extraction
Keywords: دابیگاتران ; Apixaban; Dabigatran; Direct thrombin inhibitors; Edoxaban; Factor Xa inhibitors; Rivaroxaban;
Keywords: دابیگاتران ; Idarucizumab; Andexanet alfa; DOAC; NOAC; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Antidote; Praxbind; ANNEXA-A; ANNEXA-R;
Keywords: دابیگاتران ; Dabigatran; Rivaroxaban; Apixaban; Warfarin; Praxbind; Factor Xa inhibitors; Andexanet alfa;
Keywords: دابیگاتران ; Apixaban; Bleeding management; Clinical trials; Dabigatran; Direct oral anticoagulants; Edoxaban; Rivaroxaban;
Keywords: دابیگاتران ; Anticoagulación oral; Fibrilación auricular; Dabigatran; Rivaroxaban; Apixaban; Edoxaban;
Keywords: دابیگاتران ; Anticoagulation; Novel oral anticoagulants; Rivaroxaban; Apixaban; Edoxaban; Dabigatran
Keywords: دابیگاتران ; AD; Alzheimer's disease; CST; cerebroside sulfotransferase; DE; dabigatran etexilate; VKORC1; vitamin K oxidoreductase subunit 1; GGC; gamma-glutamyl carboxylase; VKDPs; vitamin K dependent proteins; Astrocyte; Dabigatran; Microglia; Sulfatides; Vitamin K
Keywords: دابیگاتران ; Intracranial hemorrhage; Cerebral bleeding; Anticoagulants; Warfarin; Rivaroxaban; Apixaban; Dabigatran
Keywords: دابیگاتران ; Anticoagulanti; Dabigatran; Rivaroxaban; Sanguinamento; Chirurgia orale; Anticoagulants; Dabigatran; Rivaroxaban; Bleeding; Oral surgery;
Keywords: دابیگاتران ; AF; atrial fibrillation; CES-1; hepatic carboxylesterase-1; CKD-EPI; Chronic Kidney Disease Epidemiology; CKD-EPIcreat; creatinine based estimated glomerular filtration rate using ckd-epi formula; CDK-EPIcombined; combined equation to calculated estimated
Keywords: دابیگاتران ; Dabigatran; Intracerebral hemorrhage; Intracranial hemorrhage; Neurosurgical treatment; New target specific oral anticoagulants; Rivaroxaban; CT; Computed tomography; GCS; Glasgow Coma Scale; PCC; Prothrombin complex concentrate; INR; International normal
Keywords: دابیگاتران ; LC-MS/MS; Direct oral anticoagulants; Coagulation tests; Chromogenic assay; Rivaroxaban; Edoxaban; Apixaban; Dabigatran;
Keywords: دابیگاتران ; Novel anticoagulants; Bleeding; Vitamin K antagonists; Dabigatran; Rivaroxaban; Atrial fibrillation
Keywords: دابیگاتران ; Pulmonary vein thrombus; Autonomic nervous dysfunction; 64-MDCT; CVRR; Dabigatran;
Keywords: دابیگاتران ; Apixaban; Dabigatran; Intracranial hemorrhages; Rivaroxaban; Treatment outcome
Keywords: دابیگاتران ; warfarin; anticoagulation; dabigatran; rivaroxaban; apixaban;
Keywords: دابیگاتران ; Thromboembolic disease; Oral antithrombin; Thrombophlia; Thromboprophylaxis; Dabigatran
Keywords: دابیگاتران ; Tromboembolismo venoso; Dabigatrán; Rivaroxabán; Apixabán; EdoxabánVenous thromboembolism; Dabigatran; Rivaroxaban; Apixaban; Edoxaban
Keywords: دابیگاتران ; anticoagulation; apixaban; cutaneous surgery; dabigatran; novel drugs; rivaroxaban; warfarinCYP3A4, cytochrome P450 3A4; NOAC, novel oral anticoagulant; P-gp, permeability glycoprotein
Keywords: دابیگاتران ; perioperative cardiovascular evaluation; guidelines; VISION study; myocardial injury after noncardiac surgery; troponins; aspirin; clonidine; POISE-2 study; atrial fibrillation; stroke; bleeding; risks scores; dabigatran; factor Xa inhibitors; left atrial
Keywords: دابیگاتران ; Dabi; dabigatran; DTI; direct thrombin inhibitor; PT; prothrombin time; APTT; activated partial thromboplastin time; TT; thrombin time; ECA; ecarin clotting assay; HTI; Hemoclot Thrombin Inhibitors; LC-MS/MS; liquid chromatography-tandem mass spectrometry
Keywords: دابیگاتران ; Bleeding; New oral anticoagulants; Rivaroxaban; Dabigatran; Apixaban; Meta-analysis;
Keywords: دابیگاتران ; anticoagulant; antiplatelet; apixaban; blood thinners; dabigatran; dermatologic surgery; dietary supplements; prasugrel; rivaroxaban; ticagrelorADP, adenosine diphosphate; AF, atrial fibrillation; CVA, cerebrovascular accident; FDA, Food and Drug Administ
Keywords: دابیگاتران ; Anciano; Fibrilación auricular no valvular; Guías; Antagonistas de la vitamina K; Dabigatran; Rivaroxaban; Apixaban; EdoxabanElderly; Nonvalvular atrial fibrillation; Guidelines; Vitamin K antagonists; Dabigatran; Rivaroxaban; Apixaban; Edoxaban
Keywords: دابیگاتران ; Elderly; Nonvalvular atrial fibrillation; Guidelines; Vitamin K antagonists; Dabigatran; Rivaroxaban; Apixaban; EdoxabanAnciano; Fibrilación auricular no valvular; Guías; Antagonistas de la vitamina K; Dabigatran; Rivaroxaban; Apixaban; Edoxaban
Keywords: دابیگاتران ; Novel oral anticoagulants; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Cost-effectiveness; Atrial fibrillationNovos anticoagulantes orais; Apixabano; Dabigatrano; Edoxabano; Rivaroxabano; Custo-efetividade; Fibrilhação auricular
Keywords: دابیگاتران ; anticoagulation; apixaban; atrial fibrillation; cost-effectiveness; dabigatran; rivaroxaban;